Uncoupling CD4+ TIL-mediated tumor killing from JAK-signaling in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research(2023)
摘要
In conclusion, our data indicate that exploiting tumor-specific cytotoxic CD4+ TILs could help overcome resistance to ICB mediated by IFNγ-signaling loss in MHCIIconst+ melanomas.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要